Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kontafarma China Holdings Ltd ( (HK:1312) ) has shared an update.
Kontafarma China Holdings Ltd has issued a profit warning, expecting significant impairment losses across financial assets, intangible assets, and goodwill in its fitness business segment. These losses, combined with decreased revenue and gross profit in its pharmaceutical segment due to market competition, are projected to result in a substantial consolidated net loss for the first half of 2025. Despite these impairments being non-cash items, the announcement highlights challenges in the company’s financial performance and market positioning.
More about Kontafarma China Holdings Ltd
Kontafarma China Holdings Ltd operates in the fitness and pharmaceutical industries, with a focus on fitness businesses in Singapore and Taiwan through its subsidiaries. The company has acquired significant stakes in True Cayman Group and True Yoga Cayman Group, which are engaged in fitness operations in these regions.
Average Trading Volume: 1,049,094
Technical Sentiment Signal: Sell
Current Market Cap: HK$184.1M
Find detailed analytics on 1312 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money